BridgeMD
New treatment option for Bladder Carcinoma
Official title The Vanguard Study: Testing a New Way to Screen for Cancer
ClinicalTrials.gov ID: NCT06995898
What this study is testing
- What it's testing
- The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers in the blood in order to screen for multiple cancers simultaneously.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 75. Healthy volunteers may be eligible.
You may be able to join if
- Ages 45-75 years old
- Agree to provide blood samples for possible MCD testing at enrollment and at 1 year following enrollment
- Agree to allow collection of information from their medical records for study-related purposes
- Understand and be able to complete informed consent and participant questionnaires in English, Spanish, or Arabic
- Note: Eligibility for Spanish and Arabic languages are at the Hub's discretion
You likely can't join if
- Solid malignant tumor or blood cancer diagnosis, with or without treatment, within the last 5 years
- Note: Persons with a history of in situ cancers (e.g., ductal carcinoma in situ of the breast, cervical cancer in situ, atypical melanocytic...
- Ongoing cancer diagnostic work-up
- Ongoing participation in another study of an investigational cancer screening test or technology
- Currently breastfeeding or pregnant, or planning to become pregnant in the next year
The study team makes the final eligibility decision.
Where it's taking place
- Pleasanton, California, United States
- Cheyenne Wells, Colorado, United States
- Denver, Colorado, United States
- Fort Collins, Colorado, United States
- Greeley, Colorado, United States
- Lafayette, Colorado, United States
- Lone Tree, Colorado, United States
- Loveland, Colorado, United States
- Honolulu, Hawaii, United States
- Bethesda, Maryland, United States
- Brownstown, Michigan, United States
- Chesterfield, Michigan, United States
- Clinton Township, Michigan, United States
- Dearborn, Michigan, United States
- Detroit, Michigan, United States
- Grosse Pointe Farms, Michigan, United States
- Livonia, Michigan, United States
- Novi, Michigan, United States
- Plymouth, Michigan, United States
- Royal Oak, Michigan, United States
+ 14 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pleasanton, California, United States; Cheyenne Wells, Colorado, United States; Denver, Colorado, United States; Fort Collins, Colorado, United States; Greeley, Colorado, United States; Lafayette, Colorado, United States and 28 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.